GlassScriptPhysician profile
Vincent Lopez Rowe
NPI 1396777215
$11,354.06
in general payments reported to CMS, 2019-2025
29 companies · $1,464 in 2025
The $1,464 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,125 · 2020: $180 · 2021: $1,126 · 2022: $3,523 · 2023: $845 · 2024: $1,091 · 2025: $1,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,400.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,314.64 | 2021-2025 | Endurant Iis, Valiant Captivia, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $2,097.37 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Janssen Pharmaceuticals, INC | $1,663.65 | 2022 | |
| Cvrx, INC. | $1,392.40 | 2019 | |
| Cook Medical LLC | $982.70 | 2019-2025 | Zenith Alpha, Zenith Spiral-Z, Zilver Ptx |
| Endologix LLC | $413.13 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Penumbra, INC. | $359.33 | 2022-2025 | Penumbra System |
| Janssen Scientific Affairs, LLC | $315.72 | 2021-2022 | |
| Medtronic Vascular, INC. | $302.14 | 2019 | |
| Abbott Laboratories | $242.90 | 2021-2023 | Perclose Proglide |
| Balt USA, LLC | $194.09 | 2024-2025 | Prestige Coil System |
| Boston Scientific Corporation | $135.90 | 2022-2023 | Varithena Administration Pack |
| Smith+Nephew, INC. | $119.65 | 2023-2025 | Grafix Pl, Stravix, Stravix Pl |
| Medline Industries LP | $103.30 | 2019 | |
| Bolton Medical INC | $95.27 | 2023 | Treo Abdominal Stent-Graft System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $81.46 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Getinge USA Sales, LLC | $72.54 | 2019-2020 | |
| Koya Medical, INC. | $62.30 | 2025 | Koya Medical, Dayspring |
| Mimedx Group, INC. | $57.01 | 2024-2025 | |
| Humacyte Global, INC. | $55.90 | 2025 | Symvess |
| Shockwave Medical, INC | $54.63 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Solventum Corporation | $50.87 | 2024 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Lifenet Health | $39.97 | 2023 | |
| Alphatec Spine, INC | $34.48 | 2024 | Solus Alif |
| Cardiva Medical, INC. | $32.96 | 2023 | Cardiva Vascade 6/7f Vcs |
| Johnson & Johnson Health Care Systems INC. | $21.62 | 2023 | Xarelto |
| Avita Medical Americas, LLC | $20.21 | 2024 | |
| Inspiremd LTD | $19.93 | 2025 | Cguard Prime Carotid Stent System |
| Bsn Medical INC | $17.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.